Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H38O |
| Molecular Weight | 270.4937 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCCO
InChI
InChIKey=GLDOVTGHNKAZLK-UHFFFAOYSA-N
InChI=1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3
| Molecular Formula | C18H38O |
| Molecular Weight | 270.4937 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.truthinaging.com/ingredients/stearyl-alcohol
http://www.cosmeticsinfo.org/ingredient/stearyl-alcohol
Curator's Comment: description was created based on several sources, including
https://www.truthinaging.com/ingredients/stearyl-alcohol
http://www.cosmeticsinfo.org/ingredient/stearyl-alcohol
Stearyl Alcohol is long chain fatty alcohol. Stearyl alcohol is prepared from stearic acid or some fats by the process of catalytic hydrogenation. It has low toxicity. Stearyl Alcohol is used in surface-active agents, lubricants, emulsions, resins, and USP ointments and as a substitute for cetyl alcohol and antifoaming agents. Stearyl Alcohol (synthetic) has been approved as a direct food additive (DFA) ingredient, to be used under the same manufacturing practices as the natrual alcohol product. It also has indirect food additive (IFA) status for use in food containers. Stearyl Alcohol is also used as an ingredient in over-the-counter (OTC) drugs of the miscellaneous external drug product category. It is considered to be safe at a concentration of 8 percent or less. Stearyl Alcohol is used in cosmetics as an emollient, stabilizer, antifoaming agent, emulsifier, and carrier. It is used as a water in oil (w/o) emulsifier to produce firm cosmetic products at ordinary temperatures.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
multiple, topical Route: topical Route: multiple Sources: |
unhealthy, 24 years Health Status: unhealthy Age Group: 24 years Sex: F Sources: |
Disc. AE: Contact dermatitis... AEs leading to discontinuation/dose reduction: Contact dermatitis Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dermatitis | Disc. AE | multiple, topical Route: topical Route: multiple Sources: |
unhealthy, 24 years Health Status: unhealthy Age Group: 24 years Sex: F Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Fluorinated vs hydrogenated surfactants in mixtures with valinomycin--the Langmuir monolayer study. | 2010-06-01 |
|
| In vitro drug release mechanism from lipid nanocapsules (LNC). | 2010-05-10 |
|
| Monolayer structure and evaporation resistance: a molecular dynamics study of octadecanol on water. | 2010-03-25 |
|
| Star-shaped azomethines based on tris(2-aminoethyl)amine. Characterization, thermal and optical study. | 2010-02 |
|
| Simple and rapid analytical method for the simultaneous determination of cetrimonium chloride and alkyl alcohols in hair conditioners. | 2010-02 |
|
| Synthesis of novel asymmetric zinc (II) phthalocyanines bearing octadecyloxyl and glucosyl groups. | 2009-09-18 |
|
| In vitro study of antibacterial activity on multi-resistant bacteria and chemical composition of the chloroform extract of endemic Centaurea drabifolia subsp. cappadocica. | 2009-09 |
|
| The influence of bilayer composition on the gel to liquid crystalline transition. | 2009-08-06 |
|
| [Improvement of a sedimentation method for measuring dispersion of fibres from asbestos cement roofs]. | 2009-07-16 |
|
| Comparison of age-dependent quantitative changes in the male labial gland secretion of Bombus terrestris and Bombus lucorum. | 2009-06 |
|
| Phosphonium labeling for increasing metabolomic coverage of neutral lipids using electrospray ionization mass spectrometry. | 2009-06 |
|
| Allergic contact dermatitis from dichlorobenzyl alcohol in a patient with multiple contact allergies. | 2009-05 |
|
| Solid lipid nanoparticles for topical administration of Kaempferia parviflora extracts. | 2009-04 |
|
| Self-assembly of alkoxy-substituted bis(hydrazone)-based organic ligands and of a metallosupramolecular grid on graphite. | 2009-03-09 |
|
| Factors controlling the stability of a kinetically hindered lamellar-lamellar transition. | 2009-02-19 |
|
| Syntheses, phase behavior, supramolecular chirality, and field-effect carrier mobility of asymmetrically end-capped mesogenic oligothiophenes. | 2009 |
|
| In situ observation of gamma-Fe2O3 nanoparticle adsorption under different monolayers at the air/water interface. | 2008-11-18 |
|
| Stability enhancement effect of normal long-chain alcohols on ion pair amphiphile monolayers at the air/water interface. | 2008-11-15 |
|
| Development of low cost pulmonary surfactants composed of a mixture of lipids or lipids-peptides using higher aliphatic alcohol or soy lecithin. | 2008-10-15 |
|
| Axisymmetric drop shape analysis-constrained sessile drop (ADSA-CSD): a film balance technique for high collapse pressures. | 2008-10-07 |
|
| Major sex pheromone components of the Australian gum leaf skeletonizer Uraba lugens: (10E,12Z)-hexadecadien-1-yl acetate and (10E,12Z)-hexadecadien-1-ol. | 2008-09 |
|
| [Research on chemical constituents from stem of Gymnema sylvestre]. | 2008-08 |
|
| Rumen bypass and biodistribution of l-carnitine from dual-layered coated pellets in cows, in vitro and in vivo. | 2008-07-09 |
|
| Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs. | 2008-06 |
|
| Reactive uptake of N2O5 on aqueous H2SO4 solutions coated with 1-component and 2-component monolayers. | 2008-05-22 |
|
| Novel molecular precursor of lanthanide complexes with long chain mono cis-butene dicarboxylate to the controlled synthesis of Y2O3:Eu3+ phosphors. | 2008-03 |
|
| Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors. | 2008-02 |
|
| Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome. | 2008-02 |
|
| Does the solid-liquid crystal phase transition provoke the spin-state change in spin-crossover metallomesogens? | 2008-01-30 |
|
| Shape-persistent macrocycles with intraannular alkyl groups: some structural limits of discotic liquid crystals with an inverted structure. | 2008-01-09 |
|
| [Study on preparation of phenols gastric floating tablet]. | 2008-01 |
|
| Wax-incorporated emulsion gel beads of calcium pectinate for intragastric floating drug delivery. | 2008 |
|
| Chemical composition and antimicrobial activity of volatile components from capitula and aerial parts of Rhaponticum acaule DC growing wild in Tunisia. | 2008 |
|
| A novel flow reactor for studying reactions on liquid surfaces coated by organic monolayers: methods, validation, and initial results. | 2007-11-01 |
|
| The odor of origin: kinship and geographical distance are reflected in the marking pheromone of male beewolves (Philanthus triangulum F., Hymenoptera, Crabronidae). | 2007-10-10 |
|
| The effect of ethanol on the release of opioids from oral prolonged-release preparations. | 2007-10 |
|
| Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings. | 2007-07-18 |
|
| Generation and characterization of surface layers on acoustically levitated drops. | 2007-06-15 |
|
| Langmuir and Langmuir-Blodgett films of N-(4-octadecyloxy-2-hydroxybenzylidene) derivatives of amino acids. | 2007-06-01 |
|
| Formation of wormlike aggregates of fluorocarbon-hydrocarbon hybrid surfactant by Langmuir-Blodgett transfer and alignment of gold nanoparticles. | 2007-05-22 |
|
| Identification of minor sex pheromone components of the poplar clearwing moth Paranthrene tabaniformis (Lepidoptera, Sesiidae). | 2007-04-12 |
|
| Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations. | 2007-02-24 |
|
| Effect of substituent position in coumarin derivatives on the interfacial assembly: reversible photodimerization and supramolecular chirality. | 2007-02-13 |
|
| Comedogenicity in rabbit: some cosmetic ingredients/vehicles. | 2007 |
|
| The oxorhenium(VII)-catalyzed direct condensation of phosphoric acid with an alcohol. | 2007 |
|
| Design of a transdermal delivery system for aspirin as an antithrombotic drug. | 2006-12-11 |
|
| Progress in characterization of Langmuir monolayers by consideration of compressibility. | 2006-11-30 |
|
| The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. | 2006-09 |
|
| Total body topical 5-fluorouracil for extensive non-melanoma skin cancer. | 2006-06 |
|
| The scent of senescence: age-dependent changes in the composition of the cephalic gland secretion of the male European beewolf, Philanthus triangulum. | 2006 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/cdi/kinerase-cream.html
as a part of cream, losions
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/26673629
Stearyl alcohol induced expression of several secretory proteins including lipase, haemolysin-coregulated protein and nucleoside diphosphate kinase. Expression of these secreted proteins was upregulated at the transcriptional level. Stearyl alcohol also induced the synthesis of polyhydroxyalkanoate. Secretory protein EliA was required for all these responses of NT80 cells to stearyl alcohol.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:35 GMT 2025
by
admin
on
Mon Mar 31 17:48:35 GMT 2025
|
| Record UNII |
2KR89I4H1Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C76735
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
1082
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
m10202
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
37071
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID8026935
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
70
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
100000078780
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
SUB12598MIG
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
5379
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
C009316
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL24640
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
32154
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
204-017-6
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
8221
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
STEARYL ALCOHOL
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
2KR89I4H1Y
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
1622000
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
2KR89I4H1Y
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
112-92-5
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
0.2% of chemical composition of the leaf essential oil from Moringa oleifera.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |